The Journal of Immunology, Vol 153, Issue 12 5366-5372, Copyright © 1994 by American Association of Immunologists

ARTICLES

IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines

Y Aragane, H Riemann, RS Bhardwaj, A Schwarz, Y Sawada, H Yamada, TA Luger, M Kubin, G Trinchieri and T Schwarz
Ludwig Boltzmann Institute for Cellbiology and Immunobiology of the Skin, Department of Dermatology, University of Munster, Germany.

IL-12 is a 70-kDa heterodimeric cytokine composed of two covalently linked chains, p40 and p35. IL-12 has multiple effects on T and NK cells and recently was found to be required for optimal Th1 cell development. In a variety of inflammatory skin disorders including delayed type hypersensitivity and contact hypersensitivity, Th1 cells appear to be critically involved. Because keratinocytes are well known to exhibit the capacity to release a variety of proinflammatory and immunologic cytokines, and thereby to be able to modulate inflammatory and immune reactions within the skin, it was investigated whether human keratinocytes and keratinocyte cell lines can release IL-12. Supernatants of phorbol-12,13-dibutyrate (PDBu) stimulated human epidermoid carcinoma cell lines (KB, A431) induced IFN-gamma production by PBL. This activity could be completely blocked by the addition of an anti-IL-12 Ab directed against the p40 subunit of IL-12 (C8.6). Release of IL-12 by keratinocyte cell lines was further confirmed by an RIA specific for p40. Immunoprecipitation under reducing conditions using the C8.6 Ab yielded specific bands at 40 kDa in supernatants of both KB cells and normal human keratinocytes. Northern blot analysis revealed IL-12-specific mRNA transcripts in PDBu-treated KB cells using cDNA probes encoding for p35 and p40. Moreover, by reverse transcription PCR specific transcripts for p35 and p40 were found in keratinocytes. These data indicate that keratinocyte cell lines and, although to a much lesser degree, normal human keratinocytes, exhibit the capacity to make IL-12; thus demonstrating for the first time IL-12 production by nonhemopoietic cells. Thus, one may speculate that keratinocytes via this capacity may influence the fate of Th-mediated immune responses, favoring Th1 responses by enhanced production of IL-12 or Th2 responses by reduced IL-12 release.

This article has been cited by other articles:

				T. L Davis and J. L Pate Bovine Luteal Cells Stimulate Proliferation of Major Histocompatibility Nonrestricted Gamma Delta T Cells Biol Reprod, December 1, 2007; 77(6): 914 - 922. [Abstract] [Full Text] [PDF]

				A. Maeda, S. W. Schneider, M. Kojima, S. Beissert, T. Schwarz, and A. Schwarz Enhanced photocarcinogenesis in interleukin-12-deficient mice. Cancer Res., March 15, 2006; 66(6): 2962 - 2969. [Abstract] [Full Text] [PDF]

				E. Kikawada, D. M. Lenda, and V. R. Kelley IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-{gamma} Expression, and Diminishes Systemic Pathology J. Immunol., April 1, 2003; 170(7): 3915 - 3925. [Abstract] [Full Text] [PDF]

				S. Beissert, D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein, and T. Schwarz IL-12 Prevents the Inhibitory Effects of cis-Urocanic Acid on Tumor Antigen Presentation by Langerhans Cells: Implications for Photocarcinogenesis J. Immunol., December 1, 2001; 167(11): 6232 - 6238. [Abstract] [Full Text] [PDF]

				J. R. TIMOSHANKO, A. R. KITCHING, S. R. HOLDSWORTH, and P. G. TIPPING Interleukin-12 from Intrinsic Cells Is an Effector of Renal Injury in Crescentic Glomerulonephritis J. Am. Soc. Nephrol., March 1, 2001; 12(3): 464 - 471. [Abstract] [Full Text]

				M. J. Walter, N. Kajiwara, P. Karanja, M. Castro, and M. J. Holtzman Interleukin 12 p40 Production by Barrier Epithelial Cells during Airway Inflammation J. Exp. Med., January 29, 2001; 193(3): 339 - 352. [Abstract] [Full Text] [PDF]

				B. Bussolati, F. Mariano, L. Biancone, R. Foa, S. David, V. Cambi, and G. Camussi Interleukin-12 Is Synthesized by Mesangial Cells and Stimulates Platelet-Activating Factor Synthesis, Cytoskeletal Reorganization, and Cell Shape Change Am. J. Pathol., February 1, 1999; 154(2): 623 - 632. [Abstract] [Full Text] [PDF]

				M. J. Robertson and J. Ritz Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment Oncologist, February 1, 1996; 1(1): 88 - 97. [Abstract] [Full Text] [PDF]

				C. Feliciani, A.K. Gupta, and D.N. Saucier Keratinocytes and Cytokine/Growth Factors Critical Reviews in Oral Biology & Medicine, January 1, 1996; 7(4): 300 - 318. [Abstract] [Full Text] [PDF]